Cat. No.: X23-10-ZQ808
ROCK inhibitor RKI-1313, Purity ≥98%
Synonym: 1342276-76-9; RKI-1313; 1-(3-Methoxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea; 1-[(3-Methoxyphenyl)methyl]-3-(4-pyridin-4-yl-1,3-thiazol-2-yl)urea; RKI 1313; 1-[(3-Methoxyphenyl)methyl]-3-[4-(pyridin-4-yl)-1,3-thiazol-2-yl]urea; ROCK inhibitor
- MDL: MFCD27996044
- CAS Number: 1342276-76-9
- Compound CID: 53492330
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Properties
Description
RKI-1313 blocks the ATP-binding site of ROCK, thereby inhibiting its kinase activity.
Molecular Formula
C17H16N4O2S
Identity
Confirmed by NMR/HPLC/MS.
Applications
RKI-1313 can be used to study its inhibitory effects on Rho kinase and its potential therapeutic benefits in cardiovascular diseases.
Related Products
